Fundraising Fox

Vaxin

Gaithersburg, US · Delaware corporation · 1 known investors

Founders & leadership

SR
Scot RobertsExecutive
WE
William EnrightExecutive

Board

PP
Philippe PoulettyBoard directorCEO and Co-Founder at Truffle Capital
FG
Florent GrosBoard director
PH
Philip HodgesBoard director
MS
Marten SteenBoard director
KS
Klaus SchaferBoard director
DD
David DrutzBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$50M disclosed across 2 rounds · 2015

$8MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David DrutzDirector
  • Klaus SchaferDirector
  • Philip HodgesDirector
  • Scot RobertsExecutive Officer
  • Florent GrosDirector
  • Philippe PoulettyDirector
  • Marten SteenDirector
  • William EnrightExecutive Officer, Director
Offering amount
$16M
Amount sold
$8M
Minimum investment
$10
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$42MraisedMar 2015 · 60 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philippe PoulettyDirector
  • Scot RobertsExecutive Officer
  • Florent GrosDirector
  • Philip HodgesDirector
  • Klaus SchaferDirector
  • William EnrightExecutive Officer, Director
  • Marten SteenDirector
  • David DrutzDirector
Offering amount
$42M
Amount sold
$42M
Sales commissions
$520K
Placement agents
Gordian Investment, LLC
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Vaxin's investors?
Vaxin's investors include Truffle Capital.
How much funding has Vaxin raised?
Vaxin has disclosed $50M raised across 2 rounds.
Where is Vaxin headquartered?
Vaxin is headquartered in Gaithersburg, US.